These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10900534)

  • 21. Topiramate and nephrolithiasis: a response.
    Raff A; Jion YI; Grosberg BM; Evans RW
    Headache; 2015 May; 55(5):701-2. PubMed ID: 25904093
    [No Abstract]   [Full Text] [Related]  

  • 22. [Weight loss associated with topiramate treatment].
    Maciá- Bobes C; Cortejoso-García R; Carrio-Montes I; Arias Rodríguez M
    Rev Neurol; 2002 Feb 16-28; 34(4):397. PubMed ID: 12022061
    [No Abstract]   [Full Text] [Related]  

  • 23. Functional MRI reveals declined prefrontal cortex activation in patients with epilepsy on topiramate therapy.
    Jansen JF; Aldenkamp AP; Marian Majoie HJ; Reijs RP; de Krom MC; Hofman PA; Eline Kooi M; Nicolay K; Backes WH
    Epilepsy Behav; 2006 Aug; 9(1):181-5. PubMed ID: 16793345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Migraine-induced kidney stones?].
    Gerber L; Wüthrich RP; Mohebbi N
    Praxis (Bern 1994); 2012 May; 101(10):665-8. PubMed ID: 22565558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of topiramate on serum bicarbonate concentrations in adults.
    Garris SS; Oles KS
    Ann Pharmacother; 2005 Mar; 39(3):424-6. PubMed ID: 15701764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of topiramate (Topamax®) therapy on the development of aggressive and/or agitated behavior.
    Farinde A
    J Pharm Pract; 2011 Dec; 24(6):568-70. PubMed ID: 21987528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topiramate induced metabolic acidosis and kidney stones - a case study.
    Salek T; Andel I; Kurfurstova I
    Biochem Med (Zagreb); 2017 Jun; 27(2):404-410. PubMed ID: 28694730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topiramate: new indication. A bulkier assessment file.
    Prescrire Int; 1999 Oct; 8(43):141-2. PubMed ID: 11503838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Report of three cases of hyperammonaemic encephalopathy associated with valproic acid due to possible synergism with phenobarbital and topiramate].
    Cano-Zuleta A; Hernández-Ortíz OH; González-González CA; Amariles P
    Farm Hosp; 2012; 36(5):441-2. PubMed ID: 22266198
    [No Abstract]   [Full Text] [Related]  

  • 30. Predictors of weight loss in adults with topiramate-treated epilepsy.
    Ben-Menachem E; Axelsen M; Johanson EH; Stagge A; Smith U
    Obes Res; 2003 Apr; 11(4):556-62. PubMed ID: 12690085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous topiramate: safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate.
    Clark AM; Kriel RL; Leppik IE; White JR; Henry TR; Brundage RC; Cloyd JC
    Epilepsia; 2013 Jun; 54(6):1106-11. PubMed ID: 23586686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epilepsy outcomes in elderly treated with topiramate.
    Stefan H; Hubbertz L; Peglau I; Berrouschot J; Kasper B; Schreiner A; Krimmer J; Schauble B;
    Acta Neurol Scand; 2008 Sep; 118(3):164-74. PubMed ID: 18384458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients with and without prior urolithiasis have hypocitraturia and incident kidney stones while on topiramate.
    Kaplon DM; Penniston KL; Nakada SY
    Urology; 2011 Feb; 77(2):295-8. PubMed ID: 20888032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neonatal hypocalcemic seizures in siblings exposed to topiramate in utero.
    Gorman MP; Soul JS
    Pediatr Neurol; 2007 Apr; 36(4):274-6. PubMed ID: 17437916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topiramate in patients with epilepsy and intellectual disability.
    Martin P; Schreiner A; Rettig K; Schäuble B
    Epilepsy Behav; 2009 Mar; 14(3):496-502. PubMed ID: 19162230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of topiramate on acid-base balance: extent, mechanism and effects.
    Mirza N; Marson AG; Pirmohamed M
    Br J Clin Pharmacol; 2009 Nov; 68(5):655-61. PubMed ID: 19916989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central hyperventilation related to administration of topiramate.
    Laskey AL; Korn DE; Moorjani BI; Patel NC; Tobias JD
    Pediatr Neurol; 2000 Apr; 22(4):305-8. PubMed ID: 10788749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
    Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter, outpatient, open-label study to evaluate the dosing, effectiveness, and safety of topiramate as monotherapy in the treatment of epilepsy in clinical practice.
    Sankar R; Ramsay E; McKay A; Hulihan J; Wiegand F;
    Epilepsy Behav; 2009 Aug; 15(4):506-12. PubMed ID: 19643672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both?
    Latour P; Biraben A; Polard E; Bentué-Ferrer D; Beauplet A; Tribut O; Allain H
    Hum Psychopharmacol; 2004 Apr; 19(3):193-203. PubMed ID: 15079854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.